EVERINOMICIN

Everninomicin is an antibacterial agent inhibiting protein synthesis, active against grampositive bacteria. Side effects include GI upset and potential bone marrow suppression. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 0acdc3659f5c Category: Tag:

Product Description


Mechanism of Action

Everninomicin is an oligosaccharide antibiotic of the orthosomycin class that binds uniquely to the 50S ribosomal subunit at a site distinct from macrolides and aminoglycosides. By obstructing the peptidyltransferase center and disturbing 50S30S subunit interactions, it inhibits bacterial protein synthesis with strong activity against multidrugresistant grampositive organisms.

Benefits and Advantages

Used in ribosomalbinding site mapping, antimicrobial resistancemechanism studies, orthosomycin SAR research, and proteintranslation inhibition assays.

Side Effects and Risks

Risks include bonemarrow suppression, GI upset, hypersensitivity reactions and potential nephrotoxicity. Handle with highpotency antibacterial precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C94H150Cl2N2O34

Molecular Weight

1830.0 g/mol

CAS Number

11051-74-0

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

Evernimicin antibiotic complex

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download